Says the guy with 4 posts who does not hold. Clearly wants a cheap cross promotion or the SP down some more. Imminent news of the FDA decision as to whether Pivalate goes strait to phase 3 will have an impact on time to market. TLX are also 114 times our market cap, RAD is well below fair value.
Looks like top up time and wait.
News: RAD Radiopharm Theranostics Says U.S. FDA Granted Orphan Drug Designation To GA68-TRIVEHEXIN, page-43
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
